Quality Improvement Guidelines for Percutaneous Management of Acute Limb Ischemia

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 7 SUPPL., 2009, Pages

  Rajan, Dheeraj K ^a   Patel, Nilesh H ^b   Valji, Karim ^c   Cardella, John F ^d   Brown, Daniel B ^h   Brountzos, Elias N ⁱ   Clark, Timothy W I ^e   Grassi, Clement J ^j   Meranze, Steven G ^k   Miller, Donald L ^l   Neithamer, Calvin D ^m   Rholl, Kenneth ⁿ   Roberts, Anne ^c   Schwartzberg, Marc S ^o   Swan, Timothy T ^p   Thorpe, Patricia E ^q   Towbin, Richard B ^f   Sacks, David ^g  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UCSD MEDICAL CENTER   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^g READING HOSPITAL AND MEDICAL CENTER   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF ATHENS   (Greece)

^j LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^k VANDERBILT UNIVERSITY HOSPITAL   (United States)

^l WALTER REED ARMY MEDICAL CENTER   (United States)

^m Inova Mount Vernon Hospital   (United States)

ⁿ INOVA ALEXANDRIA HOSPITAL   (United States)

^o Radiology Associates of Central Florida   (United States)

^p MARSHFIELD CLINIC   (United States)

^q UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; PLASMINOGEN ACTIVATOR; PROUROKINASE; RETEPLASE; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CLINICAL PRACTICE; COMPARTMENT SYNDROME; CONTINUOUS INFUSION; DOPPLER ECHOGRAPHY; DRUG INDICATION; DRUG MEGADOSE; EMBOLISM; FIBRINOLYTIC THERAPY; HEALTH CARE QUALITY; HEPARINIZATION; HUMAN; INTERVENTIONAL RADIOLOGY; LIMB ISCHEMIA; LOW DRUG DOSE; PATIENT MONITORING; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; THROMBECTOMY; TREATMENT CONTRAINDICATION;

EID: 67649816660     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2009.04.010     Document Type: Article

References (91)

1. McNamara T.O., and Fischer J.R. Thrombolysis of peripheral arterial and graft occlusions: improved results using high-dose urokinase. AJR Am J Roentgenol 144 (1985) 769-775
2. Berridge D.C., Makin G.S., and Hopkinson B.R. Local low dose intra-arterial thrombolytic therapy: the risk of stroke or major haemorrhage. Br J Surg 76 (1989) 1230-1233
3. Durham J.D., Geller S.C., Abbott W.M., et al. Regional infusion of urokinase into occluded lower-extremity bypass grafts: long-term clinical results. Radiology 172 (1989) 83-87
4. DeMaioribus C.A., Mills J.L., Fujitani R.M., Taylor S.M., and Joseph A.E. A reevaluation of intraarterial thrombolytic therapy for acute lower extremity ischemia. J Vasc Surg 17 (1993) 888-895
5. Clouse M.E., Stokes K.R., Perry L.J., and Wheeler H.G. Percutaneous intraarterial thrombolysis: analysis of factors affecting outcome. J Vasc Interv Radiol 5 (1994) 93-100
6. Schilling J.D., Pond G.D., Mulcahy M.M., McIntyre K.E., Hunter G.C., and Bernhard V.M. Catheter-directed urokinase thrombolysis: an adjunct to PTA/ surgery for management of lower extremity thromboembolic disease. Angiology 45 (1994) 851-860
7. Ouriel K., Shortell C.K., DeWeese J.A., et al. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 19 (1994) 1021-1030
8. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg 220 (1994) 251-266
9. Faggioli G.L., Peer R.M., Pedrini L., et al. Failure of thrombolytic therapy to improve long-term vascular patency. J Vasc Surg 19 (1994) 289-296
10. Ikeda Y., Rummel M.C., Field C.K., et al. Relationship of runoff vessels to results following thrombolysis and revascularization for synthetic graft occlusions. Am Surg 61 (1995) 481-485
11. McNamara T.O., Gardner K.R., Bomb-erger R.A., and Greaser III L.E. Clinical and angiographic selection factors for thrombolysis as initial therapy for acute lower limb ischemia. J Vasc Interv Radiol 6 suppl (1995) 36S-47S
12. Schweizer J., Altmann E., Stosslein F., Florek H.J., and Kaulen R. Comparison of tissue plasminogen activator and urokinase in the local infiltration thrombolysis of peripheral arterial occlusions. Eur J Radiol 22 (1996) 129-132
13. Ouriel K., Veith F.J., and Sasahara A.A. Thrombolysis or peripheral arterial surgery: phase I results. TOPAS Investigators. J Vasc Surg 23 (1996) 64-73
14. Hess H., Mietaschk A., von Bilderling P., and Neller P. Peripheral arterial occlusions: local low-dose thrombolytic therapy with recombinant tissue-type plasminogen activator (rt-PA). Eur J Vasc Endovasc Surg 12 (1996) 97-104
15. Braithwaite B.D., Buckenham T.M., Gal-land R.B., Heather B.P., and Earnshaw J.J. Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group. Br J Surg 84 (1997) 646-650
16. Spence L.D., Hartnell G.G., Reinking G., et al. Thrombolysis of infrapopliteal bypass grafts: efficacy and underlying angiographic pathology. AJR Am J Roentgenol 169 (1997) 717-121
17. Ouriel K., Veith F.J., and Sasahara A.A. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis Or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med 338 (1998) 1105-1111
18. Wholey M.H., Maynar M.A., Pulido-Duque J.M., Reyes R., Jarmolowski C.R., and Castaneda W.R. Comparison of thrombolytic therapy of lower-extremity acute, subacute, and chronic arterial occlusions. Cathet Cardiovasc Diagn 44 (1998) 159-169
19. Lambert A.W., Trkulja D., Fox A.D., Budd J.S., Chalmers A.H., and Horrocks M. Age-related outcome for peripheral thrombolysis. Eur J Vasc Endovasc Surg 17 (1999) 144-148
20. Ouriel K., Kandarpa K., Schuerr D.M., Hultquist M., Hodkinson G., and Wallin B. Prourokinase versus urokinase for recanalization of peripheral occlusions, safety and efficacy: the PURPOSE trial. J Vasc Interv Radiol 10 (1999) 1083-1091
21. Braithwaite B.D., Tomlinson M.A., Walker S.R., Davies B., Buckenham T.M., and Earnshaw J.J. Peripheral thrombolysis for acute-onset claudication. Thrombolysis Study Group. Br J Surg 86 (1999) 800-804
22. Suggs W.D., Cynamon J., Martin B., et al. When is urokinase treatment an effective sole or adjunctive treatment for acute limb ischemia secondary to native artery occlusion?. Am J Surg 178 (1999) 103-106
23. Ouriel K., Gray B., Clair D.G., and Olin J. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis. J Vasc Interv Radiol 11 (2000) 295-298
24. Korn P., Khilnani N.M., Fellers J.C., et al. Thrombolysis for native arterial occlusions of the lower extremities: clinical outcome and cost. J Vasc Surg 33 (2001) 1148-1157
25. Swischuk J.L., Fox P.F., Young K., et al. Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: results and complications. J Vasc Interv Radiol 12 (2001) 423-430
26. Nehler M.R., Mueller R.J., McLafferty R.B., et al. Outcome of catheter-directed thrombolysis for lower extremity arterial bypass occlusion. J Vasc Surg 37 (2003) 72-78
27. Conrad M.F., Shepard A.D., Rubinfeld I.S., et al. Long-term results of catheter-directed thrombolysis to treat infrainguinal bypass graft occlusion: the urokinase era. J Vasc Surg 37 (2003) 1009-1016
28. Castaneda F., Swischuk J.L., Li R., Young K., Smouse B., and Brady T. Declining-dose study of reteplase treatment for lower extremity arterial occlusions. J Vasc Interv Radiol 13 (2002) 1093-1098
29. Duda S.H., Tepe G., Luz O., et al. Peripheral artery occlusion: treatment with abciximab plus urokinase versus with urokinase alone-a randomized pilot trial (the PROMPT Study). Platelet Receptor Antibodies in Order to Manage Peripheral Artery Thrombosis. Radiology 221 (2001) 689-696
30. Drescher P., McGuckin J., Rilling W.S., and Crain M.R. Catheter-directed thrombolytic therapy in peripheral artery occlusions: combining reteplase and abciximab. AJR Am J Roentgenol 180 (2003) 1385-1391
31. Ouriel K., Castaneda F., McNamara T., et al. Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: results from the RELAX trial. J Vasc Interv Radiol 15 (2004) 229-238
32. Earnshaw J.J., Whitman B., and Foy C. National Audit of Thrombolysis for Acute Leg Ischemia (NATALI): clinical factors associated with early outcome. J Vasc Surg 39 (2004) 1018-1025
33. Hopfner W., Vicol C., Bohndorf K., and Loeprecht H. Shredding embolectomy thrombectomy catheter for treatment of acute lower-limb ischemia. Ann Vasc Surg 13 (1999) 426-435
34. Muller-Hulsbeck S., Kalinowski M., Heller M., and Wagner S.J. Rheolytic hydrodynamic thrombectomy for percutaneous treatment of acutely occluded infra-aortic native arteries and bypass grafts: midterm follow-up results. Invest Radiol 35 (2000) 131-140
35. Kasirajan K., Gray B., Beavers F.P., et al. Rheolytic thrombectomy in the management of acute and subacute limb-threatening ischemia. J Vasc Interv Radiol 12 (2001) 413-421
36. Wagner H.J., Muller-Hulsbeck S., Pitton M.B., Weiss W., and Wess M. Rapid thrombectomy with a hydrodynamic catheter: results from a prospective, multi-center trial. Radiology 205 (1997) 675-681
37. Ansel G.M., George B.S., Botti C.F., et al. Rheolytic thrombectomy in the management of limb ischemia: 30-day results from a multicenter registry. J Endovasc Ther 9 (2002) 395-402
38. Fink A., Kosecoff J., Chassin M., and Brook R.H. Consensus methods: characteristics and guidelines for use. Am J Public Health 74 (1984) 979-983
39. Semba C.P., Tam I., and Blaney M. Re: catheter-directed thrombolytic therapy for limb ischemia: current status and controversies. J Vasc Interv Radiol 15 (2004) 517
40. Dormandy J., Heeck L., and Vig S. Acute limb ischemia. Semin Vasc Surg 12 (1999) 148-153
41. Yeager R.A., Moneta G.L., Taylor Jr. L.M., Hamre D.W., McConnell D.B., and Porter J.M. Surgical management of severe acute lower extremity ischemia. J Vasc Surg 15 (1992) 385-391
42. Ouriel K., Shortell C.K., Azodo M.V., Gutierrez O.H., and Marder V.J. Acute peripheral arterial occlusion: predictors of success in catheter-directed thrombolytic therapy. Radiology 193 (1994) 561-566
43. Blaisdell F.W., Steele M., and Allen R.E. Management of acute lower extremity arterial ischemia due to embolism and thrombosis. Surgery 84 (1978) 822-834
44. Dotter C.T., Rosch J., and Seaman A.J. Selective clot lysis with low-dose streptokinase. Radiology 111 (1974) 31-37
45. Comerota A.J., Weaver F.A., Hosking J.D., et al. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts. Am J Surg 172 (1996) 105-112
46. Diffin D.C., and Kandarpa K. Assessment of peripheral intraarterial thrombolysis versus surgical revascularization in acute lower-limb ischemia: a review of limb-salvage and mortality statistics. J Vasc Interv Radiol 7 (1996) 57-63
47. Thrombolysis in the management of lower limb peripheral arterial occlusion-a consensus document. Working Party on Thrombolysis in the Management of Limb Ischemia. Am J Cardiol 81 (1998) 207-218
48. Patel N., Sacks D., Patel R.I., et al. SIR reporting standards for the treatment of acute limb ischemia with use of transluminal removal of arterial thrombus. J Vasc Interv Radiol 14 suppl (2003) S453-S465
49. Dormandy J.A., and Rutherford R.B. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 31 suppl (2000) S1-S296
50. Shortell C.K., and Ouriel K. Thrombolysis in acute peripheral arterial occlusion: predictors of immediate success. Ann Vasc Surg 8 (1994) 59-65
51. Rutherford R.B., Baker J.D., Ernst C., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997) 517-538
52. Camerta A., and White J.V. Overview of catheter directed thrombolytic therapy for arterial and graft occlusion. In: Camerta A. (Ed). Thrombolytic therapy for peripheral vascular disease (1995), Lippincott-Raven, Philadelphia 249-252
53. Weaver F.A., Comerota A.J., Youngblood M., Froehlich J., Hosking J.D., and Papanicolaou G. Surgical revascularization versus thrombolysis for nonembolic lower extremity native artery occlusions: results of a prospective randomized trial. The STILE Investigators. Surgery versus Thrombolysis for Ischemia of the Lower Extremity. J Vasc Surg 24 (1996) 513-521
54. Thrombolytic therapy in treatment: summary of an NIH Consensus Conference. BMJ 280 6231 (1980) 1585-1587
55. NIH Consensus Development Conference. Thrombolytic therapy in thrombosis. J Fla Med Assoc 67 (1980) 1021-1025
56. McNamara T.O., and Bomberger R.A. Factors affecting initial and 6 month patency rates after intraarterial thrombolysis with high dose urokinase. Am J Surg 152 (1986) 709-712
57. Semba C.P., Bakal C.W., Calis K.A., et al. Alteplase as an alternative to urokinase. Advisory Panel on Catheter-Directed Thrombolytic Therapy. J Vasc Interv Radiol 11 (2000) 279-287
58. van Breda A., Katzen B.T., and Deutsch A.S. Urokinase versus streptokinase in local thrombolysis. Radiology 165 (1987) 109-111
59. Torrens I., Reyes O., Ojalvo A.G., et al. Mapping of the antigenic regions of streptokinase in humans after streptokinase therapy. Biochem Biophys Res Commun 259 (1999) 162-168
60. Fischer S., and Kohnert U. Major mechanistic difference explain the higher clot lysis potency of reteplase over alteplase: lack of fibrin binding is an advantage for bolus application of fibrin-specific thrombolytics. Fibrinolysis Proteinolysis 11 (1997) 129-135
61. Davidian M.M., Powell A., Benenati J.F., Katzen B.T., Becker G.J., and Zemel G. Initial results of reteplase in the treatment of acute lower extremity arterial occlusions. J Vasc Interv Radiol 11 (2000) 289-294
62. Ouriel K., Katzen B., Mewissen M., et al. Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study. J Vasc Interv Radiol 11 (2000) 849-854
63. Drescher P., Crain M.R., and Rilling W.S. Initial experience with the combination of reteplase and abciximab for thrombolytic therapy in peripheral arterial occlusive disease: a pilot study. J Vasc Interv Radiol 13 (2002) 37-43
64. Burkart D.J., Borsa J.J., Anthony J.P., and Thurlo S.R. Thrombolysis of acute peripheral arterial and venous occlusions with tenecteplase and eptifibatide: a pilot study. J Vasc Interv Radiol 14 (2003) 729-733
65. Schweizer J., Kirch W., Koch R., Muller A., Hellner G., and Forkmann L. Use of abciximab and tirofiban in patients with peripheral arterial occlusive disease and arterial thrombosis. Angiology 54 (2003) 155-161
66. Hull J.E., Hull M.K., and Urso J.A. Reteplase with or without abciximab for peripheral arterial occlusions: efficacy and adverse events. J Vasc Interv Radiol 15 (2004) 557-564
67. Shortell C.K., Queiroz R., Johansson M., et al. Safety and efficacy of limited-dose tissue plasminogen activator in acute vascular occlusion. J Vasc Surg 34 (2001) 854-859
68. Cragg A.H., Smith T.P., Corson J.D., et al. Two urokinase dose regimens in native arterial and graft occlusions: initial results of a prospective, randomized clinical trial. Radiology 178 (1991) 681-686
69. Koppensteiner R., Minar E., Ahmadi R., Jung M., and Ehringer H. Low doses of recombinant human tissue-type plasminogen activator for local thrombolysis in peripheral arteries. Radiology 168 (1988) 877-878
70. Graor R.A., Risius B., Young J.R., et al. Thrombolysis of peripheral arterial bypass grafts: surgical thrombectomy compared with thrombolysis. A preliminary report. J Vasc Surg 7 (1988) 347-355
71. Risius B., Graor R.A., Geisinger M.A., et al. Recombinant human tissue-type plasminogen activator for thrombolysis in peripheral arteries and bypass grafts. Radiology 160 (1986) 183-188
72. Verstraete M., Hess H., Mahler F., et al. Femoro-popliteal artery thrombolysis with intra-arterial infusion of recombinant tissue-type plasminogen activator-report of a pilot trial. Eur J Vasc Surg 2 (1988) 155-159
73. Earnshaw J.J., Westby J.C., Gregson R.H., Makin G.S., and Hopkinson B.R. Local thrombolytic therapy of acute peripheral arterial ischaemia with tissue plasminogen activator: a dose-ranging study. Br J Surg 75 (1988) 1196-1200
74. Benenati J., Shlansky-Goldberg R., Meglin A., and Seidl E. Thrombolytic and antiplatelet therapy in peripheral vascular disease with use of reteplase and/or abciximab. The SCVIR Consultants' Conference; May 22, 2000; Orlando, FL. Society for Cardiovascular and Interventional Radiology. J Vasc Interv Radiol 12 (2001) 795-805
75. Berridge D.C., Gregson R.H., Hopkinson B.R., and Makin G.S. Randomized trial of intra-arterial recombinant tissue plasminogen activator, intravenous recombinant tissue plasminogen activator and intra-arterial streptokinase in peripheral arterial thrombolysis. Br J Surg 78 (1991) 988-995
76. Mewissen M.W., Minor P.L., Beyer G.A., and Lipchik E.O. Symptomatic native arterial occlusions: early experience with "over-the-wire" thrombolysis. J Vasc Interv Radiol 1 (1990) 43-47
77. Sullivan K.L., Gardiner Jr. G.A., Shapiro M.J., Bonn J., and Levin D.C. Acceleration of thrombolysis with a high-dose transthrombus bolus technique. Radiology 173 (1989) 805-808
78. Kandarpa K., Chopra P.S., Aruny J.E., et al. Intraarterial thrombolysis of lower extremity occlusions: prospective, randomized comparison of forced periodic infusion and conventional slow continuous infusion. Radiology 188 (1993) 861-867
79. Valji K., Bookstein J.J., Roberts A.C., and Sanchez R.B. Occluded peripheral arteries and bypass grafts: lytic stagnation as an end point for pulse-spray pharmacomechanical thrombolysis. Radiology 188 (1993) 389-394
80. Hye R.J., Turner C., Valji K., et al. Is thrombolysis of occluded popliteal and tibial bypass grafts worthwhile?. J Vasc Surg 20 (1994) 588-596
81. Ward A.S., Andaz S.K., and Bygrave S. Thrombolysis with tissue-plasminogen activator: results with a high-dose transthrombus technique. J Vasc Surg 19 (1994) 503-508
82. Juhan C., Haupert S., Miltgen G., Girard N., and Dulac P. A new intra arterial rt-PA dosage regimen in peripheral arterial occlusion: bolus followed by continuous infusion. Thromb Haemost 65 (1991) 635
83. Comerota A.J., Rao A.K., Throm R.C., et al. A prospective, randomized, blinded, and placebo-controlled trial of intraoperative intra-arterial urokinase infusion during lower extremity revascularization. Regional and systemic effects. Ann Surg 218 (1993) 534-541
84. Gorich J., Rilinger N., Sokiranski R., et al. Mechanical thrombolysis of acute occlusion of both the superficial and the deep femoral arteries using a thrombectomy device. AJR Am J Roentgenol 170 (1998) 1177-1180
85. Uflacker R. Mechanical thrombectomy in acute and subacute thrombosis with use of the Amplatz device: arterial and venous applications. J Vasc Interv Radiol 8 (1997) 923-932
86. Tadavarthy S.M., Murray P.D., Inampudi S., Nazarian G.K., and Amplatz K. Mechanical thrombectomy with the Amplatz device: human experience. J Vasc Interv Radiol 5 (1994) 715-724
87. Henry M., Amor M., Henry I., Tricoche O., and Allaoui M. Thrombectomy with the hydrolysing catheter. Apropos of 50 cases. Arch Mal Coeur Vaiss 90 (1997) 797-804 [French]
88. Sniderman K.W., Bodner L., Saddekni S., Srur M., and Sos T.A. Percutaneous embolectomy by transcatheter aspiration. Work in progress. Radiology 150 (1984) 357-361
89. Wagner H.J., and Starck E.E. Acute embolic occlusions of the infrainguinal arteries: percutaneous aspiration embolectomy in 102 patients. Radiology 182 (1992) 403-407
90. Wagner H.J., Starck E.E., and Reuter P. Long-term results of percutaneous aspiration embolectomy. Cardiovasc Intervent Radiol 17 (1994) 241-246
91. Zehnder T., Birrer M., Do D.D., et al. Percutaneous catheter thrombus aspiration for acute or subacute arterial occlusion of the legs: how much thrombolysis is needed?. Eur J Vasc Endovasc Surg 20 (2000) 41-46